Sholeh Feizi

Dr Sholeh Feizi

Postdoctoral Researcher

Adelaide Medical School

Faculty of Health and Medical Sciences

Sholeh Feizi completed her PhD with the ENT Surgery group in 2022. Her research is focused on cellular biology and microbiology techniques; designing and conducting experiments; animal work; clinical trials, etc.

  • Journals

    Year Citation
    2024 Murphy, W., Liu, S., Javadiyan, S., Vyskocil, E., Feizi, S., Callejas, C., . . . Psaltis, A. J. (2024). An In Vitro Study Evaluating the Safety of Mesalazine on Human Nasoepithelial Cells. International Journal of Molecular Sciences, 25(5), 12 pages.
    2024 Murphy, W., Liu, S., Hon, K., Finnie, J., Bouras, G. S., Feizi, S., . . . Psaltis, A. J. (2024). A Novel Model of Staphylococcus aureus-Induced Lymphoplasmacytic Rhinosinusitis in Rats. International Journal of Molecular Sciences, 25(6), 13 pages.
    2024 Shaghayegh, G., Cooksley, C., Bouras, G., Panchatcharam, B. S., Feizi, S., Javadian, S., . . . Vreugde, S. (2024). S. aureus biofilm properties correlate with immune B cell subset frequencies and severity of chronic rhinosinusitis. Clinical Immunology, 263, 110221.
    2023 Feizi, S., Cooksley, C. M., Ramezanpour, M., Nepal, R., Psaltis, A. J., Wormald, P. J., & Vreugde, S. (2023). Colloidal silver against macrophage infections and biofilms of atypical mycobacteria. BioMetals, 36(4), 913-925.
    DOI Scopus2 WoS1 Europe PMC1
    2023 Nepal, R., Houtak, G., Bouras, G., Ramezanpour, M., Feizi, S., Shaghayegh, G., . . . Vreugde, S. (2023). Prophage acquisition by<i>Staphylococcus aureus</i>contributes to the expansion of Staphylococcal immune evasion.
    2023 Feizi, S., Awad, M., Nepal, R., Cooksley, C. M., Psaltis, A. J., Wormald, P. J., & Vreugde, S. (2023). Deferiprone-gallium-protoporphyrin (IX): A promising treatment modality against Mycobacterium abscessus. Tuberculosis, 142, 7 pages.
    2022 Feizi, S., Cooksley, C. M., Nepal, R., Psaltis, A. J., Wormald, P. -J., & Vreugde, S. (2022). Silver nanoparticles as a bioadjuvant of antibiotics against biofilm-mediated infections with methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa in chronic rhinosinusitis patients. Pathology, 54(4), 453-459.
    DOI Scopus15 WoS6 Europe PMC9
    2021 Feizi, S., Cooksley, C. M., Bouras, G. S., Prestidge, C. A., Coenye, T., Psaltis, A. J., . . . Vreugde, S. (2021). Colloidal silver combating pathogenic Pseudomonas aeruginosa and MRSA in chronic rhinosinusitis.. Colloids and surfaces. B, Biointerfaces, 202, 1-10.
    DOI Scopus14 WoS13 Europe PMC7
    2021 Feizi, S., Javadiyan, S., Cooksley, C. M., Shaghayegh, G., Psaltis, A. J., Wormald, P., & Vreugde, S. (2021). Green synthesized colloidal silver is devoid of toxic effects on primary human nasal epithelial cells in vitro. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 157, 112606-1-112606-10.
    DOI Scopus6 WoS2 Europe PMC1
    2018 Feizi, S., Taghipour, E., Ghadam, P., & Mohammadi, P. (2018). Antifungal, antibacterial, antibiofilm and colorimetric sensing of toxic metals activities of eco friendly, economical synthesized Ag/AgCl nanoparticles using Malva Sylvestris leaf extracts. Microbial Pathogenesis, 125, 33-42.
    DOI Scopus47 WoS35 Europe PMC14
    2017 Abbasi, Z., Feizi, S., Taghipour, E., & Ghadam, P. (2017). Green synthesis of silver nanoparticles using aqueous extract of dried Juglans regia green husk and examination of its biological properties. Green Processing and Synthesis, 6(5), 477-485.
    DOI Scopus36 WoS21
  • Position: Postdoctoral Researcher
  • Email:
  • Campus: Queen Elizabeth Hospital
  • Building: Institute Building
  • Org Unit: Adelaide Medical School

Connect With Me
External Profiles